Louisiana Finally Gets a Medical Cannabis Program after Two Years of Delay


Patients in Louisiana to receive Marijuana supply in May following the resolution of the longstanding friction between the Louisiana Department of Agriculture and Forestry (LDAF) and LSU.

After more than a year of a standoff between the Department of Agriculture and Forestry and the two medical marijuana license holders in the state, it seems that patients will receive a limited supply of flower in May. However, the broader roll-out of the program that was formerly approved in 2016 by the legislators will have to wait at least until August.

The two holders of medical marijuana license in Louisiana include Southern University and Louisiana State University, which are both based in Baton Rouge. These two holders are required to cultivate and distribute medical marijuana products by the state law in collaboration with a private partner. In 2017, Louisiana State University ( LSU) partnered with GB Sciences, which is based in Nevada while Southern University contracted with Advanced Biomedics, a company in Louisiana. However, Southern University later scrapped the partnership and contracted Ilera Holistic Healthcare, which is based in Pennsylvania.

The two universities have not had an easy ride in becoming a cannabis cultivator, as the process was full of challenges. For LSU, the process was particularly bumpy as Louisiana Agricultural Commissioner Mike Strain publicly and repeatedly referenced administrative delays between the university and the required paperwork from the business partner and regulatory timeline of the state. However, on March 22 GB Sciences was allowed to begin the cultivation of cannabis in its main facility at Louisiana State University

“Since the selection of GB in September 2017, the GB Sciences Louisiana and LSU AgCenter have diligently worked on this initiative,” said William Richardson (LSU Vice President for Agriculture) in a public statement. “We are delighted to have completed this milestone, and we also look forward to ensuring that patients in Louisiana receive the much-needed product.”

According to Medical marijuana patients advocates, the product should be widely available to patients in Louisiana by mid-May.

GB Sciences had harvested two cannabis crops in a small modular facility on Louisiana State University before moving into the main facility last week. However, the sole lab-testing authority in the state is solely held by the LDAF, which has not yet completed final testing on the concentrate products from the company intended for sale. The LDAF canceled the independent testing lab license applications earlier this year and took on the task itself, a move that lead to another public outcry.

“Each contested result is handled on a case-by-case basis since every circumstance is different. Thus we do not have a particular policy in place,” said Laura Lindsay, LDAF spokeswoman in her statement to the Baton Rouge Advocate. “This means that the contested results of medical marijuana will be treated in the same manner as other contested results of any other substance under the department’s regulation. Usually, we will contract with an independent lab to confirm the specific contest result if a result is contested.”

The state is currently working on completing the final testing on batches of cannabis concentrates at the modular facility at GB Sciences. “We will do everything that it takes to ensure that we meet the deadline,” said Louisiana GB Sciences president in his statement at “stakeholders meeting” held on 25th March. This was in response to the questions raised on whether cannabis products will be available to patients by May 15.

Long-term Delays

The LSU and the department have had publicly derided relationship that led to yearlong delays, before the mood became more optimistic just three weeks ago. “In every step of the way, they have fought, thus publicly deriding their relationship,” said John Davis while talking to USA Today Network in early March.” This was when he was describing the regulatory obligations at the school. “We have sent a notice to the school informing them that they have violated the law and we intend to proceed to court.”

However, public records give a very different story.

Three weeks before Strain’s accusations on Feb. 13, the LSU AgCenter coordinator, Dr. Ashley Mullens had sent a letter to the director of the medical marijuana program in the state in an attempt to ensure that LSU records meet state demands. The letter captures months of endless disputes and long stretches of radio silence among state agencies, including the Gaming Enforcement Division of the Louisiana State Police, which is responsible for “suitability” checks for those who apply for medical marijuana licenses.

Mullen’s letter chronicles series of contradictions and miscommunications that leave GB Sciences in the resubmitting paperwork as well as amending “deficiencies” that were not well explained. “From August 2017, GB Sciences and its partners have been working towards compliance with suitability process requested by LDAF,” Mullens wrote. The firm has responded to each request and supplemental request. Therefore, suggesting that GB Sciences has only submitted suitability information recently would be a misrepresentation of the documented history.”

GB submitted several new suitability applications to the state applications for people who had been identified by the state’s police for the first in December 2018, leading to more confusing into 2019. “Consequently, GB Sciences was required to start a process over what it attempted to begin in the past.”

However, it is only in February that the obstacles began to clear.

The state’s director of the medical marijuana program, Tabitha Irvin responded to Mullens and said. “In an effort to avail products to the pharmacies for the citizens of Louisiana and after careful consideration, the commissioner of agriculture and forestry has decided to give LSU AgCenter the authority to move plant material into requested rooms (Vegetation room and Mother room) in the main facility.”

Nevertheless, once GB Sciences did this, the state insisted that the company had violated the state’s medical marijuana law, rules and regulations. This initiated the public duel that took place in March.

As of now, patients may soon receive cannabis products after nearly three years since the legalization of the medical marijuana industry in the state. But, Ilera Holistic Healthcare (Southern University’s partner) is yet to start growing cannabis plants.


Medcare 2023 event

Terms and Conditions for Entry into Medcare Farms Puff Party(Required)
| Age Requirement: You confirm that you are 21 years of age or older at the time of entering the Event. Valid government-issued photo identification must be presented upon request. | Compliance with Laws: You agree to comply with all federal, state, and local laws and regulations, including those pertaining to the use, possession, and distribution of any substances allowed or provided at the Event. | Liability Waiver: You acknowledge that participation in the Event is at your own risk. Medcare Farms, its affiliates, sponsors, representatives, and employees are not liable for any personal injury, loss, damages, or expenses incurred by you or any person accompanying you to the Event. | No Resale or Transfer: Your entry to the Event is personal to you; tickets or invitations cannot be sold, transferred, or exchanged for any compensation without the express permission of Medcare Farms. | Conduct: You agree to conduct yourself in a manner that is respectful and safe. Medcare Farms reserves the right to remove any participant from the Event for behavior deemed inappropriate, disruptive, or dangerous, without refund or compensation. | Use of Likeness: You grant Medcare Farms and its affiliates the right to use your likeness, image, and voice in photographs, videos, or other digital media taken at the Event, in any and all of its publications, including web-based publications, without payment or other consideration. | Privacy: Personal information collected during the survey and registration process will be used in accordance with Medcare Farms’ Privacy Policy. This information will be used for event management and, unless you opt-out, for informing you of future events and promotions. | Indemnification: You agree to indemnify and hold harmless Medcare Farms and its affiliates, officers, employees, and agents from and against any claims, liabilities, damages, losses, and expenses, including without limitation, reasonable attorney fees and costs, arising out of or in any way connected with your participation in the Event. | Acceptance of Risk: You acknowledge that there are inherent risks involved in attending the Event and that you voluntarily assume those risks. | Severability: If any term or provision of these Terms and Conditions is found to be invalid, illegal, or unenforceable, the remainder of the Terms and Conditions will remain in full force and effect. | Governing Law: These Terms and Conditions shall be governed by and construed in accordance with the laws of the state in which the Event is held, without giving effect to any principles of conflicts of law. | By checking this box, I confirm that I have read, understood, and agree to be bound by these Terms and Conditions.

Related Articles

Puff Party 2023

Medcare Farm’s Puff Party 2023 Welcome to Medcare Farms’ 2023 Puff Party, Complete our brief entry form to enjoy live

Read More »
Med CareLogo large

Are you over 21 years old?

Call Now Button